Collaborative Research and Development Agreements (Tables)
 12 Months Ended
Dec. 31, 2013
Agreement With Gsk
  
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under our agreement with GSK (in thousands): 

 

 

 

Year ended December 31,

 

 

 

2013

 

 

2012

 

 

2011

 

Initial payment

 

$

1,702

 

 

$

1,428

 

 

$

1,428

 

Milestone revenue

 

 

-

 

 

 

-

 

 

 

15,000

 

Total

 

$

1,702

 

 

$

1,428

 

 

$

16,428

 

 
Astra Zeneca
  
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands):

 

 

 

Year ended December 31,

 

 

 

2013

 

 

2012

 

 

2011

 

Initial payments

 

$

720

 

 

$

720

 

 

$

120

 

Performance of research activities

 

 

2,507

 

 

 

2,462

 

 

 

642

 

Total

 

$

3,227

 

 

$

3,182

 

 

$

762

 

 
National Institutes of Health
  
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands):

 

 

 

Year ended December 31,

 

 

 

2013

 

 

2012

 

 

2011

 

NIAID contracts

 

$

4,103

 

 

$

3,571

 

 

$

2,730

 

All other NIH contracts

 

 

1,035

 

 

 

368

 

 

 

380

 

Total grant revenue

 

$

5,138

 

 

$

3,939

 

 

$

3,110